Photodynamic therapy in Argentina.
1Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP), CONICET and Hospital de Clínicas José de San Martín, University of Buenos Aires, Córdoba 2351 1er Subsuelo; Buenos Aires 1120, Argentina.
Photodiagnosis and Photodynamic Therapy
|July 23, 2014
Summary
Photodynamic therapy (PDT) utilizes 5-aminolevulinic acid (ALA) to generate porphyrins for cancer treatment. Research in Argentina explores ALA derivatives, delivery methods, and new photosensitizers to advance PDT applications.
Area of Science:
- Biochemistry
- Photodynamic Therapy
- Oncology
Background:
- 5-aminolevulinic acid (ALA) administration induces endogenous Protoporphyrin IX, a key component in photodynamic therapy (PDT).
- Porphyrin synthesis from ALA in plant tissues was first reported in 1975, followed by observations of increased porphyrin synthesis and photosensitization in tumors.
- Research groups in Argentina are actively investigating ALA and its derivatives for various therapeutic applications.
Purpose of the Study:
- To explore novel synthetic lipophilic derivatives of ALA and liposomal delivery systems.
- To investigate the mechanisms of ALA transport in mammalian and yeast cells.
- To examine the interactions between ALA-PDT and nitric oxide in murine adenocarcinoma cell lines.
- To synthesize new porphyrin-derived photosensitizers for photoinactivation of bacterial and mammalian cells.
- To develop cost-effective light sources for PDT.
Main Methods:
- Administration of 5-aminolevulinic acid (ALA) to induce endogenous Protoporphyrin IX.
- Synthesis of lipophilic ALA derivatives and liposomal delivery systems.
- Elucidation of ALA transport mechanisms in mammalian and yeast cells.
- Investigation of ALA-PDT interactions with nitric oxide in vitro.
- Synthesis and evaluation of novel porphyrin-derived photosensitizers.
- Design and construction of a 630nm noncoherent light source prototype.
Main Results:
- Demonstrated porphyrin synthesis from ALA in plant tissues.
- Observed increased porphyrin synthesis and cell photosensitization in tumors.
- Elucidated ALA transport mechanisms in mammalian and yeast cells.
- Investigated interactions between ALA-PDT and nitric oxide.
- Synthesized new photosensitizers for PDT applications.
- Developed a prototype 630nm light source.
Conclusions:
- ALA-based PDT shows promise for cancer treatment and microbial photoinactivation.
- Further research into ALA derivatives, delivery systems, and photosensitizers is warranted.
- Development of accessible light sources and increased physician awareness are crucial for wider PDT adoption.
